These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 10273511)
1. Prospective reimbursement and the diffusion of new technologies in hospitals. Romeo AA; Wagner JL; Lee RH J Health Econ; 1984 Apr; 3(1):1-24. PubMed ID: 10273511 [TBL] [Abstract][Full Text] [Related]
2. The diffusion of innovations in hospitals. Some econometric considerations. Lee RH; Waldman DM J Health Econ; 1985 Dec; 4(4):373-80. PubMed ID: 10276360 [TBL] [Abstract][Full Text] [Related]
3. Prospective reimbursement and new hospital services. Russell LB J Health Econ; 1984 Apr; 3(1):77-81. PubMed ID: 10273512 [No Abstract] [Full Text] [Related]
4. To buy or not to buy. Technology acquisition under prospective payment. Anderson G; Steinberg E N Engl J Med; 1984 Jul; 311(3):182-5. PubMed ID: 6429532 [No Abstract] [Full Text] [Related]
5. Equipment acquisition under prospective pricing. Goodhart M Hosp Cap Finance; 1985; 2(4):7-8. PubMed ID: 10274580 [No Abstract] [Full Text] [Related]
7. Prospective payment for hospital capital by Medicare: issues and options. Sloan FA; Valvona J Health Care Manage Rev; 1986; 11(2):25-33. PubMed ID: 3519530 [TBL] [Abstract][Full Text] [Related]
8. Lessons from New Jersey. Hospitals acquiring equipment under prospective pricing can learn from others experienced with the system. Wasserman J Hospitals; 1983 Dec; 57(23):76, 78. PubMed ID: 6685688 [No Abstract] [Full Text] [Related]
9. Prospective payment for capital costs: incentive for good management. Zuckerman A; Dix L Hosp Purch Manage; 1986 Feb; 11(2):3-6. PubMed ID: 10275477 [TBL] [Abstract][Full Text] [Related]
10. Reimbursement for new technologies: the GERD maze is not patient-friendly. Schwaitzberg SD Medscape J Med; 2008 Jan; 10(1):14. PubMed ID: 18324324 [No Abstract] [Full Text] [Related]
11. Reimbursement for capital costs. Cleverley WO Top Health Care Financ; 1979; 6(1):127-39. PubMed ID: 483318 [No Abstract] [Full Text] [Related]
13. Prospective payment: implications for medical technology. Ball JR Ann Intern Med; 1984 Apr; 100(4):606-7. PubMed ID: 6538391 [No Abstract] [Full Text] [Related]
14. A reader and author respond to "Reimbursement for new technologies: the GERD maze is not patient-friendly". Fekety JC Medscape J Med; 2008 Feb; 10(2):34; author reply 34. PubMed ID: 18382704 [No Abstract] [Full Text] [Related]
15. Diagnosis related group prospective payment: implications for health care and medical technology. Davis K; Anderson G; Steinberg E Health Policy; 1984; 4(2):139-47. PubMed ID: 10310958 [TBL] [Abstract][Full Text] [Related]
16. Capital expenditure issues falling into the realm of statutory innovation. Gayer GK Bus Health; 1984 May; 1(6):44-5. PubMed ID: 10273497 [No Abstract] [Full Text] [Related]
17. The effects of PPS on the medical supply industry. Allen PJ Hospitals; 1984 Jul; 58(13):64, 67-8. PubMed ID: 6539751 [No Abstract] [Full Text] [Related]
19. Current status of clinical laboratory reimbursement. Panning R Clin Lab Sci; 2014; 27(2):119-26. PubMed ID: 25000656 [No Abstract] [Full Text] [Related]
20. Reflections on medical technology as a special type of capital. Some implications for the hospital. Field MG Int J Technol Assess Health Care; 1987; 3(2):275-80. PubMed ID: 10284925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]